Research Roundup: The HIV and AIDS and STIs edition
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC member the International Partnership for Microbicides (IPM) announced last week the results of two phase 3 clinical trials demonstrating that a monthly vaginal ring filled with the antiretroviral drug dapivirine can reduce the risk of HIV infection in women.
As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.
GHTC member TB Alliance announced last week the creation of the first-ever child-friendly tuberculosis (TB) medicines, which are currently undergoing regulatory review by the World Health Organization and should be available in early 2016.